2009-11-10 02:33:01 -
Clarient, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com www.companiesandmarkets.com/Summary-Company-Profile/clarient,-in ..
Clarient, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary
Clarient, Inc. (Clarient) is a cancer diagnostic company engaged in providing cellular assessment and cancer characterization. The company also focuses on providing critical oncology testing services to community pathologists, biopharmaceutical companies and other researchers. It provides a range of cancer diagnostic and consultative services which include technical laboratory services and
professional interpretation. The company has its operations across the US. It is headquartered at Aliso Viejo in California, the US. In June 2009, the company launched a new gene mutation test that helps select therapy for Non-Small Cell Lung Cancer.
The Clarient, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the companys key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the companys major recent financial deals.
Scope
- Provides key company information for business intelligence needs
- Gives information on the companys major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the companys history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
Reasons to buy
- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.
